Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures

Parkinson’s disease (PD) is a multi-stage neurodegenerative disorder with largely unknown etiology. Recent findings have identified PD-associated autoimmune features including roles for T cells. To further characterize the role of T cells in PD, we performed RNA sequencing on PBMC and peripheral CD4 and CD8 memory T cell subsets derived from PD patients and age-matched healthy controls. When the groups were stratified by their T cell responsiveness to alpha-synuclein (α-syn) as a proxy for an ongoing inflammatory autoimmune response, the study revealed a broad differential gene expression profile in memory T cell subsets and a specific PD associated gene signature. We identified significant enrichment of transcriptomic signatures previously associated with PD, including for oxidative stress, phosphorylation, autophagy of mitochondria, cholesterol metabolism and inflammation, and the chemokine signaling proteins CX3CR1, CCR5, and CCR1. In addition, we identified genes in these peripheral cells that have previously been shown to be involved in PD pathogenesis and expressed in neurons, such as LRRK2, LAMP3, and aquaporin. Together, these findings suggest that features of circulating T cells with α-syn-specific responses in PD patients provide insights into the interactive processes that occur during PD pathogenesis and suggest potential intervention targets.

[1]  M. Heneka,et al.  Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes , 2021, Cell.

[2]  Samantha M. Carlisle,et al.  Sex-based differences in the activation of peripheral blood monocytes in early Parkinson disease , 2021, NPJ Parkinson's disease.

[3]  M. Tansey,et al.  Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease? , 2021, NPJ Parkinson's disease.

[4]  D. Tang,et al.  Single-Cell RNA Sequencing Reveals the Expansion of Cytotoxic CD4+ T Lymphocytes and a Landscape of Immune Cells in Primary Sjögren’s Syndrome , 2021, Frontiers in Immunology.

[5]  A. Desautels,et al.  Novel Associations of BST1 and LAMP3 With REM Sleep Behavior Disorder , 2021, Neurology.

[6]  D. Sulzer,et al.  A dual role for α-synuclein in facilitation and depression of dopamine release from substantia nigra neurons in vivo , 2020, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Shaikh,et al.  Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson's disease: Potential clinical and therapeutic implications. , 2020, Pharmacological research.

[8]  S. Mallal,et al.  α-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson’s disease , 2020, Nature Communications.

[9]  Fumito Ito,et al.  CX3CR1-CD8+ T cells are critical in antitumor efficacy, but functionally suppressed in the tumor microenvironment. , 2020, JCI insight.

[10]  F. Fiesel,et al.  Autophagy in Parkinson's disease. , 2020, Journal of molecular biology.

[11]  K. Jeong,et al.  Chronic Infiltration of T Lymphocytes into the Brain in a Non-human Primate Model of Parkinson’s Disease , 2020, Neuroscience.

[12]  Jiahong Lu,et al.  Pharmacological enhancement of TFEB-mediated autophagy alleviated neuronal death in oxidative stress-induced Parkinson’s disease models , 2020, Cell Death & Disease.

[13]  Bjoern Peters,et al.  Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease , 2019, Cell reports.

[14]  Z. Asemi,et al.  Aquaporin 4: A key player in Parkinson's disease , 2019, Journal of cellular physiology.

[15]  S. Park,et al.  Cholesterol Metabolism in the Brain and Its Association with Parkinson’s Disease , 2019, Experimental neurobiology.

[16]  I. Jonassen,et al.  Common gene expression signatures in Parkinson’s disease are driven by changes in cell composition , 2019, bioRxiv.

[17]  N. Samadi,et al.  Oxidative stress and Parkinson’s disease: conflict of oxidant-antioxidant systems , 2019, Neuroscience Letters.

[18]  E. Masliah,et al.  Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment. , 2019, Free radical biology & medicine.

[19]  D. Sulzer,et al.  The physiological role of α‐synuclein and its relationship to Parkinson’s Disease , 2019, Journal of neurochemistry.

[20]  P. van Endert Faculty Opinions recommendation of Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice. , 2019, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.

[21]  S. Mallal,et al.  Widespread Tau-Specific CD4 T Cell Reactivity in the General Population , 2019, The Journal of Immunology.

[22]  H. McBride,et al.  Intestinal infection triggers Parkinson’s disease-like symptoms in Pink1−/− mice , 2019, Nature.

[23]  M. Reinders,et al.  Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease , 2019, bioRxiv.

[24]  F. Blandini,et al.  Role of Autophagy in Parkinson's Disease. , 2019, Current medicinal chemistry.

[25]  C. Webber,et al.  RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes , 2019, Neurobiology of Disease.

[26]  J. Kordower,et al.  Low-Dose Maraviroc, an Antiretroviral Drug, Attenuates the Infiltration of T Cells into the Central Nervous System and Protects the Nigrostriatum in Hemiparkinsonian Monkeys , 2019, The Journal of Immunology.

[27]  S. Mallal,et al.  Dengue-specific CD8+ T cell subsets display specialized transcriptomic and TCR profiles , 2019, The Journal of clinical investigation.

[28]  R. Mailman,et al.  Brain cholesterol metabolism and Parkinson's disease , 2019, Movement disorders : official journal of the Movement Disorder Society.

[29]  S. Kügler,et al.  β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration , 2019, Nature.

[30]  Kieran R. Campbell,et al.  Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes , 2019, Cell stem cell.

[31]  Michael Johnson,et al.  Triggers, Facilitators, and Aggravators: Redefining Parkinson’s Disease Pathogenesis , 2019, Trends in Neurosciences.

[32]  P. J. Norris,et al.  Cutting Edge: Transcriptional Profiling Reveals Multifunctional and Cytotoxic Antiviral Responses of Zika Virus–Specific CD8+ T Cells , 2018, The Journal of Immunology.

[33]  Olga T. Schubert,et al.  The in silico human surfaceome , 2018, Proceedings of the National Academy of Sciences.

[34]  H. Ni,et al.  The Role of LRRK2 in Neurodegeneration of Parkinson Disease , 2018, Current neuropharmacology.

[35]  B. Becher,et al.  T cells in patients with narcolepsy target self-antigens of hypocretin neurons , 2018, Nature.

[36]  M. Dubinsky,et al.  Anti–Tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease , 2018, JAMA neurology.

[37]  A. Stepan,et al.  LRRK2 activation in idiopathic Parkinson’s disease , 2018, Science Translational Medicine.

[38]  C. Tanner,et al.  Prevalence of Parkinson’s disease across North America , 2018, npj Parkinson's Disease.

[39]  A. Ballabio,et al.  Overexpression of TFEB Drives a Pleiotropic Neurotrophic Effect and Prevents Parkinson's Disease-Related Neurodegeneration. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[40]  Richard J Smeyne,et al.  Mutant LRRK2 mediates peripheral and central immune responses leading to neurodegeneration in vivo , 2018, Brain : a journal of neurology.

[41]  Julie G. Burel,et al.  Transcriptomic Analysis of CD4+ T Cells Reveals Novel Immune Signatures of Latent Tuberculosis , 2018, The Journal of Immunology.

[42]  Tomas Åkerud,et al.  Structure and biophysical characterization of the human full-length neurturin–GFRa2 complex: A role for heparan sulfate in signaling , 2018, The Journal of Biological Chemistry.

[43]  Bjoern Peters,et al.  Precursors of human CD4+ cytotoxic T lymphocytes identified by single-cell transcriptome analysis , 2018, Science Immunology.

[44]  S. Mallal,et al.  T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.

[45]  S. Mallal,et al.  T cells of Parkinson’s disease patients recognize α–synuclein peptides , 2017, Nature.

[46]  C. Sankhla,et al.  Oxidative stress and Parkinson's disease , 2017, Neurology India.

[47]  L. Parnetti,et al.  Therapeutic potential of autophagy-enhancing agents in Parkinson’s disease , 2017, Molecular Neurodegeneration.

[48]  C. Webber,et al.  Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson’s disease , 2017, Human molecular genetics.

[49]  U. V. von Andrian,et al.  The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8 T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis. , 2016, Immunity.

[50]  Daniela Berg,et al.  Advances in markers of prodromal Parkinson disease , 2016, Nature Reviews Neurology.

[51]  G. Gao,et al.  Dysregulation of autophagy and mitochondrial function in Parkinson’s disease , 2016, Translational Neurodegeneration.

[52]  L. Waldron,et al.  Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array , 2015, Clinical Cancer Research.

[53]  Ruedi Aebersold,et al.  A Mass Spectrometric-Derived Cell Surface Protein Atlas , 2015, PloS one.

[54]  B. Morrison,et al.  Parkinson’s disease and enhanced inflammatory response , 2015, Experimental biology and medicine.

[55]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[56]  L. Tan,et al.  The role of the LRRK2 gene in Parkinsonism , 2014, Molecular Neurodegeneration.

[57]  Daphne Koller,et al.  Polarization of the Effects of Autoimmune and Neurodegenerative Risk Alleles in Leukocytes , 2014, Science.

[58]  H. McBride,et al.  Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control , 2014, The EMBO journal.

[59]  Åsa K. Björklund,et al.  Full-length RNA-seq from single cells using Smart-seq2 , 2014, Nature Protocols.

[60]  A. Björklund,et al.  TFEB , 2013 .

[61]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[62]  O. Hwang Role of Oxidative Stress in Parkinson's Disease , 2013, Experimental neurobiology.

[63]  W. Poewe,et al.  Toll-like receptor 4 is required for α-synuclein dependent activation of microglia and astroglia , 2013, Glia.

[64]  M. Schwartz,et al.  Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates , 2013, Nature Reviews Immunology.

[65]  J. Trojanowski,et al.  Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice , 2012, Science.

[66]  J. Vance Dysregulation of cholesterol balance in the brain: contribution to neurodegenerative diseases , 2012, Disease Models & Mechanisms.

[67]  D. Klionsky,et al.  The role of autophagy in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.

[68]  L. Stefanis α-Synuclein in Parkinson's disease. , 2012, Cold Spring Harbor perspectives in medicine.

[69]  Jianhua Zhang,et al.  Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling , 2011, The Biochemical journal.

[70]  Karen Marder,et al.  Genome-Wide association study identifies candidate genes for Parkinson's disease in an Ashkenazi Jewish population , 2011, BMC Medical Genetics.

[71]  Andrea Ballabio,et al.  TFEB Links Autophagy to Lysosomal Biogenesis , 2011, Science.

[72]  Helga Thorvaldsdóttir,et al.  Molecular signatures database (MSigDB) 3.0 , 2011, Bioinform..

[73]  Robert A. Edwards,et al.  Quality control and preprocessing of metagenomic datasets , 2011, Bioinform..

[74]  J. Andersen,et al.  Mitochondrial alpha-synuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo , 2010, Neuroscience Letters.

[75]  M. Farrer,et al.  LRRK2 and Parkinson disease. , 2010, Archives of neurology.

[76]  Alvis Brazma,et al.  A CD8 T cell transcription signature predicts prognosis in autoimmune disease , 2010, Nature Medicine.

[77]  E. Masliah,et al.  Phosphorylation of Synucleins by Members of the Polo-like Kinase Family* , 2009, The Journal of Biological Chemistry.

[78]  Kenneth G. C. Smith,et al.  Novel expression signatures identified by transcriptional analysis of separated leucocyte subsets in systemic lupus erythematosus and vasculitis , 2009, Annals of the rheumatic diseases.

[79]  M. Parihar,et al.  Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. , 2009, The international journal of biochemistry & cell biology.

[80]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[81]  R. Nussbaum,et al.  Mitochondrial translocation of alpha-synuclein is promoted by intracellular acidification. , 2008, Experimental cell research.

[82]  M. Parihar,et al.  Mitochondrial association of alpha-synuclein causes oxidative stress , 2008, Cellular and Molecular Life Sciences.

[83]  Peter T Lansbury,et al.  Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. , 2008, The Journal of clinical investigation.

[84]  Wen-wei Li,et al.  Localization of &agr;-synuclein to mitochondria within midbrain of mice , 2007, Neuroreport.

[85]  N. Hattori,et al.  Sept4, a Component of Presynaptic Scaffold and Lewy Bodies, Is Required for the Suppression of α-Synuclein Neurotoxicity , 2007, Neuron.

[86]  Heikki Tanila,et al.  Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in α‐synuclein knockout and A30P transgenic mice , 2006, Journal of neurochemistry.

[87]  Matthew J. Farrer,et al.  LRRK2 in Parkinson's disease: protein domains and functional insights , 2006, Trends in Neurosciences.

[88]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[89]  M. Beal,et al.  Neurotoxicity and behavioral deficits associated with Septin 5 accumulation in dopaminergic neurons , 2005, Journal of neurochemistry.

[90]  T. Dawson,et al.  Parkin-associated Parkinson’s disease , 2004, Cell and Tissue Research.

[91]  R. Ransohoff,et al.  Three or more routes for leukocyte migration into the central nervous system , 2003, Nature Reviews Immunology.

[92]  Christian Haass,et al.  Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant α-Synuclein in Human and Transgenic Mouse Brain , 2000, The Journal of Neuroscience.

[93]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[94]  M. L. Schmidt,et al.  α-Synuclein in Lewy bodies , 1997, Nature.

[95]  A. Torroni,et al.  Mitochondrial oxidative phosphorylation defects in parkinson's disease , 1991, Annals of neurology.

[96]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[97]  Thomas R. Gingeras,et al.  STAR: ultrafast universal RNA-seq aligner , 2013, Bioinform..

[98]  L. Rochester,et al.  Neurorehabilitation in Parkinson disease. , 2013, Handbook of clinical neurology.

[99]  Stanley Fahn,et al.  Neurodegeneration and neuroprotection in Parkinson disease , 2011, NeuroRX.

[100]  T. Dawson,et al.  The role of parkin in familial and sporadic Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[101]  D. Price,et al.  Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. , 2006, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[102]  P. Jenner,et al.  Oxidative stress in Parkinson's disease , 2003, Annals of neurology.

[103]  M G Spillantini,et al.  Alpha-synuclein in Lewy bodies. , 1997, Nature.